drugset / Trial / NCT02822222
Safety Study of RMJH-111b to Treat Essential Hypertension
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study was to evaluate the safety of RMJH-111b, including how well it is tolerated, and the effect of RMJH-111b on blood pressure in subjects with hypertension. The study also measured the amount of magnesium in the blood and urine before and after RMJH-111b administration to evaluate what the body does to RMJH-111b (pharmacokinetics).
Timeline
- Start
- 2016-06-10
- Primary completion
- 2016-07-07
- Completion
- 2016-07-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Magnesium citrate, tribasic anhydrous | Unknown | 440 mg | Oral |